940.0500 -9.95 (-1.05%)
NSE Sep 23, 2025 15:31 PM
Volume: 27,542
 

940.05
-1.05%
Motilal Oswal
Alembic Pharma (ALPM) delivered operationally in-line 3QFY25 performance. Higher interest outgo and tax led to lower-than-expected earnings for the quarter.
Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
More from Alembic Pharmaceuticals Ltd.
Recommended